Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia

Leukemia. 2016 Aug;30(8):1753-6. doi: 10.1038/leu.2016.30. Epub 2016 Feb 15.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aminoglycosides / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Female
  • Gemtuzumab
  • Humans
  • Leukemia, Mast-Cell / drug therapy*
  • Neoplasm Recurrence, Local / drug therapy*
  • Salvage Therapy / methods*

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Gemtuzumab